Clinical and pathogenetic differences of the course of flow nonalcoholic steatohepatitis in obese patients with and without hypertension

Authors

  • O.S. Khukhlina Bukovina State Medical University, Chernivtsi, Ukraine,
  • O.E. Mandryk Bukovina State Medical University, Chernivtsi, Ukraine,
  • A.A. Antoniv Bukovina State Medical University, Chernivtsi, Ukraine,

DOI:

https://doi.org/10.14739/2310-1237.2013.2.17800

Keywords:

nonalcoholic steatohepatitis, obesity, hypertension

Abstract

The article is devoted to the study of clinical and pathogenetic peculiarities of nonalcoholic steatohepatitis, a condition of components of connective tissue, metabolic intoxication, hemostasis and fibrinolysis by comorbidity with and without stage II hypertension. It was found that in the course of comorbid nonalcoholic steatohepatitis with hypertension and obesity compared with nonalcoholic steatohepatitis  without hypertension there is a higher intensity of hemostasiological disorders.

References

Успенский Ю.П. Метаболический синдром и неалкогольныйстеатогепатит: причинно-следственный континуум / Ю.П.Успенский, Е.В.Балукова // Гастроэнтерол. – 2009. – №1. – С. 43–46.

Харченко Н.В. Неалкогольныйстеатогепатиткакпроявлениеметаболическогосиндрома. Современныеподходы к лечению / Н.В. Харченко, Е.В. Родонежская // Новости мед. и фармации. – 2007. – Тем. номер «Гастроэнтерология», №226. – С. 18–19.

Хухліна О.С. Неалкогольна жирова хвороба печінки та інсулінорезистентність: патогенез, клініка, діагностика, лікування глутаргіном / О.С.Хухліна, М.Ю.Коломоєць. – Чернівці, 2008. – 318с.

Bohinc B.N. Mechanisms of Disease Progression in NASH: New Paradigms / B.N.Bohinc, A.M.Diehl // Clin.LiverDis. – 2012. – Vol.16, №3. –Р. 549–565.

Fujii H. Inflammation and fibrogenesis in steatohepatitis /H.Fujii, N.Kawada // J.Gastroenterol. – 2012. – Vol.47, №3. – P. 215–225.

NASH isanInflammatory Disorder: Pathogenic, Prognostic and Therapeutic Implications / Farrell G.C., van Rooyen D., Gan L., Chitturi S. // GutLiver. – 2012. – Vol.6, №2. – P.149–171.

Targher G. Non-alcoholic fatty liver disease, the metabolic syndrome and the risk of cardiovascular disease: the plotthickens / G. Targher // Diabet. Med. – 2007. –Vol.24, №1. – P.1–6.

Torres D.M. Features, diagnosis, and treatment of nonalcoholic Fatty liver disease / Torres D.M., Williams C.D., Harrison S.A. // Clin.Gastroenterol.Hepatol. – 2012. – Vol.10, №8. –P. 837–858.

How to Cite

1.
Khukhlina O, Mandryk O, Antoniv A. Clinical and pathogenetic differences of the course of flow nonalcoholic steatohepatitis in obese patients with and without hypertension. Pathologia [Internet]. 2013Sep.30 [cited 2024Nov.23];(2). Available from: http://pat.zsmu.edu.ua/article/view/17800

Issue

Section

Original research